Retraction to: Oncogene https://doi.org/10.1038/onc.2008.122, published online 28 April 2008
The Editors-in-Chief have retracted this article. A number of concerns were raised after publication. Specifically:
-
In figure 3A, the panel for Mock U251 and AD-SV U251 appear to partially overlap
-
In figure 3B, the panel for Mock U251 and AD-SV U251 appear to partially overlap
-
In supplementary figure 2A, the first Mock panel and a panel for 50 MOI Ad-MMP-2 with hrVEGF appear to overlap
The Editors have lost confidence in the data and conclusions of this article.
Author Odysseas Kargiotis disagrees with this retraction. The publisher could not obtain a recent email address for authors Meena Gujrati, Sajani S. Lakka, Chandramu Chetty, and Jasti S. Rao. All other authors did not respond to correspondence from the Publisher about this retraction.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Kargiotis, O., Chetty, C., Gondi, C.S. et al. Retraction Note to: Adenovirus-mediated transfer of siRNA against MMP-2 mRNA results in impaired invasion and tumor-induced angiogenesis, induces apoptosis in vitro and inhibits tumor growth in vivo in glioblastoma. Oncogene 44, 1320 (2025). https://doi.org/10.1038/s41388-025-03377-1
Published:
Issue date:
DOI: https://doi.org/10.1038/s41388-025-03377-1
